김수영

임상조교수
  #갑상선암#갑상선결절#갑상선기능항진증#갑상선기능저하증

학력

2009.10 스위스 취리히 의과대학 졸업
2009.10 스위스 의사면허 취득
2010.05 스위스 취리히 의과대학 의학박사
2011.01 한국 의사면허 취득

경력

2003-2009 스위스 취리히 의과대학 졸업
2007-2010 Swiss HBP (Hepato-Pancreato-Biliary) Center, Department of Visceral and Transplanatation Surgery, University Hospital Zurich, Switzerland에서 박사과정
2010.1-2011.2 연세대학교 세브란스병원 심혈관연구소
2011.3-2012.2 연세대학교 세브란스병원 인턴
2012.3-2016.2 연세대학교 세브란스병원 외과 전공의
2016.3-2017.2 연세대학교 강남세브란스병원 외과학교실 갑상선내분비외과 강사
2017.2-2019.3 연세대학교 강남세브란스병원 외과학교실 갑상선내분비외과 임상연구조교수
2019.3- 현재 연세대학교 강남세브란스병원 외과학교실 갑상선내분비외과 임상조교수

논문

2020 Transoral endoscopic thyroidectomy using the vestibular approach with an endoscopic retractor in thyroid cancer: experience with the first 132 patients SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

2020 Synergistic anticancer activity of sorafenib, paclitaxel, and radiation therapy on anaplastic thyroid cancer in vitro and in vivo HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

2020 Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

2020 Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis FRONTIERS IN ENDOCRINOLOGY

2020 Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up FRONTIERS IN ENDOCRINOLOGY

2020 Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer CANCERS

2019 Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe ANZ JOURNAL OF SURGERY

2019 Cost for treatment and follow-up of thyroid cancer increases according to the severity of disease Head & Neck

2019 Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea Frontiers in Endocrinology

2019 Disease Pathway Cut for Multi-Target drugs BMC BIOINFORMATICS

2018 SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with altnernating Sorafenib and Lenvatinib for refractory thyroid cancer BMC CANCER

2018 Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma MEDICINE

2018 Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells NEOPLASIA

2018 Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes WORLD JOURNAL OF SURGERY

2017 Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

2017 Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy PLOS ONE

2017 Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer NEOPLASIA

2015 The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses INTERNATIONAL JOURNAL OF CANCER

2013 Robot-assisted Posterior Retroperitoneoscopic Adrenalectomy Using Single-port Access: Technical Feasibility and Preliminary Results ANNALS OF SURGICAL ONCOLOGY

2012 Red blood cell distribution width predicts early mortality in patients with acute dyspnea. CLINICA CHIMICA ACTA

2012 Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients. CIRCULATION JOURNAL

2011 C-reactive protein induces p53-mediated cell cycle arrest in H9c2 cardiac myocytes BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

저서

저서 내용이 없습니다.

보도자료

보도자료 내용이 없습니다.

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.